Deutsche Bank’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Deutsche Bank’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,600	Closed	-$19K	–	4470
2022 Q1	$19K	Sell	11,600 -1,242	-10%	-$2.22K	﹤0.01%	4066
2021 Q4	$31K	Buy	12,842 +612	+5%	+$2.49K	﹤0.01%	4075
2021 Q3	$67K	Sell	12,230 -357	-3%	-$2.21K	﹤0.01%	4037
2021 Q2	$94K	Buy	12,587 +3,968	+46%	+$28.1K	﹤0.01%	4166
2021 Q1	$70K	Sell	8,619 -735	-8%	-$8.01K	﹤0.01%	4144
2020 Q4	$85K	Buy	9,354 +4,248	+83%	+$34.8K	﹤0.01%	3933
2020 Q3	$57K	Sell	5,106 -334	-6%	-$2.31K	﹤0.01%	3831
2020 Q2	$40K	Buy	5,440 +1,790	+49%	+$12K	﹤0.01%	3914
2020 Q1	$22K	Sell	3,650 -228	-6%	-$1.49K	﹤0.01%	3893
2019 Q4	$19K	Buy	3,878 +2,486	+179%	+$15.8K	﹤0.01%	4320
2019 Q3	$9K	Sell	1,392 -3,208	-70%	-$27.8K	﹤0.01%	4547
2019 Q2	$52K	Buy	+4,600	New	+$67K	﹤0.01%	4500

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Deutsche Bank's KLDO Position: Q2 2022 in Review

Deutsche Bank sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 11,600 shares — an estimated $19K sold.

Deutsche Bank first reported a position in KLDO in Q2 2019 and held it in 12 quarters. The position peaked at $94K in Q2 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Deutsche Bank reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 11,600 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $19K.
Deutsche Bank first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
Deutsche Bank's Kaleido Biosciences, Inc. Common Stock position peaked at $94K in Q2 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.